Goldman discloses combined ~$75M stake in CAPR, SLS, and IBRX
GS Goldman Sachs Group Inc
$1051.31 +1.14%
View chart & analysis → 
- 1Goldman Sachs files disclosure of combined ~$75M stake in Capricor (CAPR), Cel-Sci (SLS), and ImmunityBio (IBRX)
- 2Increased Capricor stake by 73% (1.58M shares, $38M) and Cel-Sci stake by 5.2% (585,035 shares, $8.64M)
- 3All three biotechs approaching key milestones including FDA reviews, clinical top-line readouts, and commercialization
This 3-line summary is compiled from the report below.
Stocktwits +1 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다